Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

BUY
$209.01 - $232.56 $27,589 - $30,697
132 Added 8.89%
1,616 $353,000
Q4 2023

Jan 23, 2024

BUY
$197.69 - $227.29 $24,118 - $27,729
122 Added 8.96%
1,484 $337,000
Q3 2023

Oct 31, 2023

BUY
$201.05 - $221.7 $273,830 - $301,955
1,362 New
1,362 $273,000
Q1 2023

May 08, 2023

SELL
$213.32 - $257.83 $10,239 - $12,375
-48 Reduced 4.91%
929 $213,000
Q3 2022

Nov 14, 2022

BUY
$204.81 - $262.19 $9,626 - $12,322
47 Added 5.05%
977 $200,000
Q4 2021

Feb 02, 2022

BUY
$271.6 - $314.21 $6,790 - $7,855
25 Added 2.76%
930 $292,000
Q3 2021

Nov 09, 2021

BUY
$274.82 - $308.34 $248,712 - $279,047
905 New
905 $255,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Tempus Wealth Planning, LLC Portfolio

Follow Tempus Wealth Planning, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tempus Wealth Planning, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tempus Wealth Planning, LLC with notifications on news.